Therapeutic effects of anti ‐Bone Morphogenetic Protein and Activin Membrane‐Bound Inhibitor treatment in psoriasis and arthritis

ConclusionsWe identify BAMBI as a promising new therapeutic target for chronic ‐inflammatory diseases and other pathological conditions modulated by Tregs.

Source: Arthritis and Rheumatology - April 5, 2020 Category: Rheumatology Authors: Pilar Alvarez, Juan Jes ús Augustín, Esther Tamayo, Marcos Iglesias, Olga Acinas, M Angeles Mendiguren, José Andrés Vázquez, Fernanda Genre, David San Segundo, Jesús Merino, Ramón Merino Tags: FULL LENGTH Source Type: research